Physician profile
John C Chan
NPI 1861473605
$14,474.01
in general payments reported to CMS, 2019-2025
32 companies · $3,969 in 2025
The $3,969 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,339 · 2020: $166 · 2021: $2,117 · 2022: $776 · 2023: $662 · 2024: $4,443 · 2025: $3,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,757 · Travel and Lodging: $4,250 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,756.68 |
| Travel and Lodging | $4,250.43 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $8,076.47 | 2019-2025 | Persona, Oxford, Rosa |
| Smith+Nephew, INC. | $1,715.51 | 2019-2025 | Pico 14, Renasys Touch, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Coastal Medical Technologies LLC | $1,158.41 | 2023-2025 | |
| Arthrex, INC. | $1,032.57 | 2019-2025 | |
| Stryker Corporation | $751.99 | 2019-2024 | Inspace, 1788, Ortholoc 2 Lapifuse |
| Medtronic, INC. | $309.85 | 2021-2025 | Mazor X System, Intellis Adaptivestim |
| Ethicon US, LLC | $303.50 | 2019-2025 | Vistaseal, Evarrest |
| Innovation Technologies INC | $251.54 | 2020-2025 | Irrisept |
| Depuy Synthes Sales INC. | $129.19 | 2019-2021 | |
| Integra Lifesciences Corporation | $117.42 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $97.82 | 2021-2025 | Durolane, Durolane, Exogen Ultrasound Bone Healing System |
| Ironshore Pharmaceuticals INC. | $56.22 | 2021-2023 | Jornay Pm |
| Acell, INC. | $47.00 | 2019 | |
| Acumed LLC | $35.18 | 2025 | Acumed, Osteomed |
| Orthofix Medical, INC. | $31.05 | 2019-2023 | Physio-Stim |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $30.52 | 2023 | Seglentis |
| Argentum Medical | $29.19 | 2021 | |
| Baxter Healthcare | $28.06 | 2019 | |
| Sanara Medtech INC. | $28.01 | 2021 | |
| Avanos Medical | $27.28 | 2019 | |
| Janssen Biotech, INC. | $26.87 | 2022 | |
| Molnlycke Health Care US, LLC | $26.30 | 2022 | |
| Tris Pharma INC | $24.44 | 2019 | |
| Pacira Therapeutics, INC. | $20.51 | 2019 | |
| Davol INC. | $19.92 | 2024 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $18.08 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.40 | 2023 | Iovera, Zilretta, Exparel |
| Sonex Health, INC. | $15.20 | 2022 | |
| Medtronic USA, INC. | $14.49 | 2020 | |
| Vertiflex, INC. | $14.00 | 2019 | |
| Convatec INC. | $12.45 | 2022 | |
| Penumbra, INC. | $8.57 | 2023 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.